Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Pharmacol Pharm Sci ; 2022: 3299146, 2022.
Article in English | MEDLINE | ID: mdl-35800399

ABSTRACT

Antimicrobial resistance to commercially available medications has become a global issue, yet there is still the possibility of developing new drugs from medicinal plants. As a result, the aims of the present study were to screen secondary metabolites and to evaluate in vitro antifungal activities of Brucea antidysenterica, Aloe vera, and Justicia schimperiana. After the plants were identified, their leaves were collected, washed, dried under the shade, pulverized, and extracted with methanol (99.8%) using the maceration technique. The presence of secondary metabolites in plant extracts was screened using various laboratory protocols. The antifungal activities of the plant extract against reference fungal strains of Candida albicans and Aspergillus niger at concentrations of 200, 100, and 50 mg/mL were assessed using the agar-well diffusion method. Ketoconazole (15 µg) was used as a positive control, while 5% dimethyl sulfoxide and/or 5% Tween 80 were used as negative controls. All tests were conducted in triplicate. Alkaloids, flavonoids, and phenols were secondary metabolites found in all plant extracts. The extract of leaves of B. antidysenterica and J. schimperiana formed a mean zone of inhibition of 15.5 ± 0.5 mm and 15.3 ± 0.58 mm, respectively, against Candida albicans at a concentration of 200 mg/mL, whereas extracts of A. vera leaves formed a 12.3 ± 0.58 mm inhibition zone only against Aspergillus niger at 200 mg/mL. In conclusion, the current study found that B. antidysenterica, A. vera, and J. schimperiana had antifungal activity. In addition, all these plants had a variety of secondary metabolites that possibly have antifungal activities. Studies on in vivo investigations and isolation of specific antifungal compounds from these medicinal plants are suggested.

2.
Vet Med (Auckl) ; 13: 59-64, 2022.
Article in English | MEDLINE | ID: mdl-35211393

ABSTRACT

BACKGROUND: Ovine oestrosis is an economically important and widely distributed parasitic disease of sheep that is caused by Oestrus ovis larvae across the world. Despite the fact that Oestrus ovis is a common parasite in Ethiopia and that there are many sheep in the study area, there is no information on the prevalence, larval burden, predilection sites, and risk factors associated with Oestrus ovis infestation in sheep in the Dendi district of West Shewa Zone, Ethiopia. METHODS: A cross-sectional study was conducted from November 2017 to April 2018, to estimate the prevalence, risk factors, and larval burden, and identify common predilection sites for Oestrus ovis larvae. A total of 180 sheep heads were randomly selected from five purposely selected restaurants in Ginchi town, Dendi district, transported to the laboratory, opened with a hand saw, and visually examined for infestations. The larvae were collected from positive sheep heads and counted. The sites where the larvae were obtained were recorded. The data were analyzed using SPSS version 20 software. RESULTS: Of the total of 180 examined sheep heads, 104 (57.8%) were infested with larvae of Oestrus ovis. In the study, a statistically significant difference (p > 0.05) was not observed in the prevalence of Oestrus ovis in relation to all considered risk factors such as sex, age, and origin of sheep. From 104 infested sheep, a total of 664 larvae were detected in different parts of sheep heads. The mean larval intensity per infected animal with Oestrus ovis was 6.38. In this study, the minimum and maximum numbers of larvae recovered were 1 and 26, respectively. The nasal cavity, nasal sinus and frontal sinus were the predilection sites of Oestrus ovis larvae identified in this study. CONCLUSION: Oestrosis is an important and common parasitic disease of sheep in the study area.

3.
J Exp Pharmacol ; 13: 511-520, 2021.
Article in English | MEDLINE | ID: mdl-34040458

ABSTRACT

BACKGROUND: Although traditional healers in Ethiopia have a long history of using medicinal plants to treat diseases in animals and humans, studies on the antibacterial activities and potential bioactive ingredients of most medicinal plants have been insufficient. Therefore, this study aimed to evaluate the in-vitro antibacterial activities and to screen phytochemical constituents of selected medicinal plants against reference bacterial strains. METHODS: The fresh and healthy roots of Echinops amplexicaulis, fruits of Ruta chalepensis, and leaves of Salix subserrata were collected from West Shewa Zone, Ethiopia. Agar well diffusion and agar dilution methods were used to evaluate antibacterial activities and minimum inhibitory concentrations (MIC). All the crude plant extracts were tested against Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli and Pseudomonas aeruginosa at concentrations of 100, 50, and 25 mg/mL in each triplet (3x). MIC of crude extracts ranging from 1.5625 to 12.50 mg/mL was applied to all bacterial strains. The positive control was ciprofloxacin disk (5 µg) and the negative control was 5% dimethyl sulfoxide. The presence of secondary metabolites of each crude extract was screened. The group means comparisons were done using one-way ANOVA and results were presented as mean ± standard deviation. RESULTS: Although all selected plant extracts had shown antibacterial activities, methanol extracts had a greater zone of inhibition against all reference bacterial strains when compared to petroleum ether extracts. The growth of P. aeruginosa was inhibited at a minimum concentration of both methanol and petroleum extracts (1.5625 mg/mL) when compared to the remaining bacterial strains. Phytochemical screening showed that saponins and alkaloids were found in all crude plant extracts, while phytosterol was meager. CONCLUSION: This study revealed that all tested plants had significant secondary metabolites and antibacterial activities against reference bacterial strains.

4.
Infect Drug Resist ; 14: 987-998, 2021.
Article in English | MEDLINE | ID: mdl-33737821

ABSTRACT

PURPOSE: Mastitis is one of the major global problems severely affecting the dairy sector. Staphylococcus species are the primary bacteria consistently identified from mastitic milk. This study was aimed to estimate the prevalence of mastitis, isolate Staphylococcus species, determine risk factors, and the antimicrobial susceptibility profile of Staphylococcus species from mastitic Zebu cows in West Shewa Zone, Ethiopia. MATERIALS AND METHODS: A total of 404 lactating Zebu cows were tested for mastitis. Isolation and identification of Staphylococcus from mastitis positive samples were done by bacteriological culture and biochemical tests. Further identification of coagulase-negative Staphylococcus (CNS) species and antimicrobial susceptibility test of the Staphylococcus aureus and the CNS was done by the Phoenix machine. Descriptive statistics was used to summarize the prevalence of mastitis while the Chi-square test and logistic regression were used to determine the association between the prevalence of mastitis and the risk factors and the magnitude of association, respectively. RESULTS: The present study showed an overall cow and quarter level mastitis prevalence of 30.5% (95% confidence interval [CI]:26.0-35.2) and 8.3% (95% CI 7.0-9.8), respectively. The quarter level isolation rate of Staphylococcus species was 38.6% (95% CI: 30.1-47.6). Five Staphylococcus species namely S. intermedius, S. hyicus, S. aureus, S. lentus, and S. sciuri were identified. The latter two are CNS and were identified for the first time in Ethiopia. Antimicrobial susceptibility testing showed none of the isolates of S. aureus, 100% of S. sciuri, and 87.5% of S. lentus species were multidrug-resistant. The independent predictors of mastitis (p<0.05) were the age of the cows, stage of lactation, type of housing, the interval of bedding cleaning, and previous history of mastitis. CONCLUSION: The study showed a high prevalence of mastitis, Staphylococcus species, and multidrug resistant S. lentus, and S. sciuri in Zebu cows.

5.
Parasit Vectors ; 8: 612, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26627056

ABSTRACT

BACKGROUND: Camel mange is an economically important parasitic disease affecting productivity in camel rearing areas of the world if appropriate treatment is not instituted. METHODS: A cross-sectional and a controlled field trial were carried out to study the epidemiology of camel mange in Fafan zone, Eastern Ethiopia, and evaluate the efficacy of ivermectin and diazinon in the control of mange infestation in camels on the basis of clinical and parasitological evidence, respectively. Three groups of naturally infested camels and one group of healthy camels each composed of 6 individuals were enrolled: the two infested groups received either ivermectin or diazinon, and the other groups remained untreated. RESULTS: The overall prevalence rate of mange in camels in the study area was 31.5% and the only identified species was Sarcoptes scabiei. The prevalence rate was found to significantly vary (p < 0.05) in relation to body condition and herd size of camels. Both drugs showed significant variation (p < 0.05) on improving clinical and body condition scores. Clearance of mange lesions occurred with both drugs; however, re-infestation was observed in diazinon treated group. Ivermectin significantly improved (p < 0.05) both body condition and clinical scores whereas diazinon markedly improved only the later. CONCLUSION: In conclusion, camels in the study area harbored considerable level of S. scabiei which warrants institution of an integrated control approach by administration of ivermectin while also sanitating the animal environment.


Subject(s)
Camelus , Insecticides/administration & dosage , Mite Infestations/veterinary , Sarcoptes scabiei/growth & development , Animals , Cross-Sectional Studies , Diazinon/administration & dosage , Ethiopia/epidemiology , Ivermectin/administration & dosage , Mite Infestations/drug therapy , Mite Infestations/epidemiology , Mite Infestations/parasitology , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL
...